Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Avastin for aggressive and late-stage cervical cancer
FDA approves Avastin for aggressive and late-stage cervical cancer
FDA approves Avastin for aggressive and late-stage cervical cancer
Submitted by
admin
on August 15, 2014 - 5:37am
Source:
Pharmaforum
News Tags:
FDA
cervical cancer
Avastin
Genentech
Roche
Headline:
FDA approves Avastin for aggressive and late-stage cervical cancer
Do Not Allow Advertisers to Use My Personal information
